Intellectual Property Rights in Covaxin – Part 1 (Waiver of IPRs)

(This post has been co-authored by Anik Bhaduri and myself. Anik is a fourth year student at NALSAR University of Law, Hyderabad.) A recent piece in the Economic Times argued that the Indian government should buy out the intellectual property rights to Covaxin, to bolster the commitment to its WTO proposal along with South Africa, to waive all IPRs on patents, copyright, industrial design and undisclosed information pertaining to vaccines for Covid-19 (covered previously on the blog here, here and … Continue reading Intellectual Property Rights in Covaxin – Part 1 (Waiver of IPRs)